Fox News health commentator Dr. Kelly Powers was diagnosed with glioblastoma, an aggressive form of brain cancer, in July ...

Chimerix’s dordaviprone shows potential for glioma treatment with a possible FDA approval by 2025. Read why CMRX stock is a ...

Steven C. Stitzel, “Stitz”, a resident of Ohio, passed away from complications from a Glioblastoma Brain Tumor on his 78th ...

Dr. Bobby plans to undergo brain surgery to have the tumor removed. He will remain awake during the procedure to answer ...

Mukkamala said physicians suspect the tumor is a grade 2 or 3 glioma, with survival rates varying depending on the diagnosis.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.IM06wodO.js ...

Chimerix (NASDAQ:CMRX) announced that, following extensive dialogue with the FDA, the company plans to submit a complete New ...

Abbie Humphries has died from a brain tumour aged 30. She hit the headlines when she was just a few hours old after a woman ...

Chimerix’s stock performance has been a rollercoaster ride in 2024. Year-to-date (YTD), it’s down by nearly 9.90%. In stark contrast, the S&P 500 index has soared by 26.90% YTD. Despite this gap, the ...

Research shows that GBM organoids are a powerful, accurate tool for understanding what happens when treating a brain tumor ...

Researchers say they developed an AI-powered model that can pinpoint remaining cancerous brain tumor parts for potential ...